Overview
Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation.
Background
Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation.
Indication
For treatment, in combination with heparin, of acute coronary syndrome, including patients who are to be managed medically and those undergoing PTCA or atherectomy.
Associated Conditions
- Cardiovascular Events
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2018/01/23 | Not Applicable | UNKNOWN | The First Affiliated Hospital of Zhengzhou University | ||
2017/11/29 | Phase 2 | Terminated | Capital Medical University | ||
2017/04/14 | Phase 4 | Completed | |||
2017/03/13 | Phase 1 | UNKNOWN | |||
2017/02/09 | N/A | Terminated | |||
2016/11/30 | Phase 4 | Completed | |||
2014/11/19 | Phase 4 | UNKNOWN | Second Hospital of Jilin University | ||
2014/05/06 | Phase 4 | Completed | |||
2014/02/04 | Phase 4 | Completed | |||
2013/01/11 | Phase 1 | Completed |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20183522 | 化学药品 | 注射剂 | 12/5/2023 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20247115 | 化学药品 | 注射剂 | 5/30/2024 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20183516 | 化学药品 | 注射剂 | 11/30/2023 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20203050 | 化学药品 | 注射剂 | 2/25/2020 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20183523 | 化学药品 | 注射剂 | 11/19/2023 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20233655 | 化学药品 | 注射剂 | 6/7/2023 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20203013 | 化学药品 | 注射剂 | 1/21/2020 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20183306 | 化学药品 | 注射剂 | 4/23/2023 | |
| Tirofiban Hydrochloride and Sodium Chloride Injection | 国药准字H20041165 | 化学药品 | 注射剂 | 8/27/2020 | |
| Tirofiban Hydrochloride for Injection | 国药准字H20153204 | 化学药品 | 注射剂 | 5/29/2020 |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||